Rhumbline Advisers »

Cerevel Therapeutics Hldng I shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0M 94k 42.40
2023-09-30 $1.9M 88k 21.83
2023-06-30 $2.8M 88k 31.79
2023-03-31 $2.0M 84k 24.39
2022-12-31 $2.5M 80k 31.54
2022-09-30 $2.0M 70k 28.26
2022-06-30 $1.6M 62k 26.44
2022-03-31 $1.4M 41k 35.01
2021-12-31 $1.2M 37k 32.42
2021-09-30 $1.1M 37k 29.50
2021-06-30 $724k 28k 25.63